Daniel Sepúlveda-Crespo

Dr. Daniel Sepúlveda-Crespo

Instituto de Salud Carlos III, Madrid, Spain
orcid
Miguel Servet postdoctoral researcher

Biography

Dr. Daniel Sepúlveda-Crespo earned his Chemical Engineering degree (2005-10) and Master's in Industrial Processes Engineering (2011) at UCM. In 2016, he earned the International Ph.D. mention in Molecular Biosciences from the UAM with a Summa Cum Laude distinction. During his pre- and postdoctoral positions at HGUGM (2012-18), he focused on developing novel nanocompounds for topical vaginal microbicides, aiming to prevent HIV and other sexually transmitted infections, including HSV-2 and HCV. His research enhanced the understanding of virus/host interactions emphasizing his commitment to translating research into tangible societal benefits. In 2018, he secured a postdoctoral contract at ULe through the JCyL/FEDER, redirecting his focus to drug discovery for neglected tropical diseases caused by human-threatening parasites, including gastrointestinal helminths. In 2019, he received the ONCE Foundation scholarship award 'Opportunity for Talent', securing it for two consecutive years for a research stay at CNM-ISCIII. In 2021, he obtained a Sara Borrell contract to investigate the impact of HCV elimination in HIV/HCV coinfected patients, assessing neutralizing antibodies against HCV and biomarkers linked to severe liver disease and HCV clearance during anti-HCV therapy. Currently, he led a project with a Miguel Servet contract, shifting his focus to novel dendritic nanosystems for diagnosing emerging viruses like Dengue or West Nile.

Affiliations

Instituto de Salud Carlos III

Madrid, Spain

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.